S31
	
		Andreas Arnell
	
					
					
	
	Lonza Biologics plc
	Applied Protein Services
	The Portway
	Granta Park
	Cambridge CB21 6GS, UK
	
	
	
	
	Papers:
	S31 
	Developability and pre-process risk assessment in biopharmaceutical development: a critical aspect in QbD implementation 
	
